Glimshine MP 1mg/500mg/7.5mg Tablet SR
Marketer
Shinemax Pharma India Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Glimshine MP 1mg/500mg/7.5mg Tablet SR
Diabetic patients with type 2 mellitus can benefit from GlucoTone-MP 1mg/500mg/7.5mg SR tablets, a triple-action formula designed to manage blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances insulin efficacy, leading to improved blood sugar regulation. Always adhere to your physician's prescribed dosage and frequency; taking this medication with food minimizes potential stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling up on doses to prevent hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping elevates the risk of hypoglycemia; regular blood glucose monitoring is essential. Common side effects might include nausea, diarrhea, abdominal pain, headache, increased fracture risk, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before using this medication. Renal function tests will be conducted prior to treatment initiation. Limit alcohol intake to reduce the likelihood of adverse events.
Uses of Glimshine MP 1mg/500mg/7.5mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimshine MP 1mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimshine MP 1mg/500mg/7.5mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimshine MP 1mg/500mg/7.5mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimshine MP 1mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimshine MP 1mg/500mg/7.5mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with food.
How Glimshine MP 1mg/500mg/7.5mg Tablet SR works:
Glimshine MP 1mg/500mg/7.5mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual medications prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimshine MP 1mg/500mg/7.5mg SR tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimshine MP 1mg/500mg/7.5mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimshine MP 1mg/500mg/7.5mg tablet may pose a risk during lactation. Available human data indicates potential transfer to breast milk, potentially harming the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glimshine MP 1mg/500mg/7.5mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Avoid prescribing Glimshine MP 1mg/500mg/7.5mg SR tablets to patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimshine MP 1mg/500mg/7.5mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is recommended. The use of Glimshine MP 1mg/500mg/7.5mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimshine MP 1mg/500mg/7.5mg Tablet SR :
Should you forget a dose of Glimshine MP 1mg/500mg/7.5mg Extended-Release Tablet, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimshine MP 1mg/500mg/7.5mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently